Emily Leongini Featured in Q&A with Marijuana Business Daily
Emily offers some insight into how cannabis companies can avoid certain missteps in the way they market their products, given that this has been one area where FDA has taken enforcement action, issuing warning letters to companies marketing CBD products with false or unsubstantiated claims. Emily stresses that companies should be prepared to back up any claims they make about their products, particularly if they claim to diagnose, mitigate, treat, or cure a disease. Emily also recommends that businesses build quality into their products by adopting a quality management system and good manufacturing practices, including drafting and following standard operating procedures, validating manufacturing processes and analytical methods, creating a system for receiving and handling consumer complaints, and ensuring employees are adequately trained to perform their functions.
Click here to read the full interview.
- Related Industries